Literature DB >> 23695338

Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication.

Andrew W Gardner1, Donald E Parker2, Polly S Montgomery3, Steve M Blevins4, April M Teague5, Ana I Casanegra6.   

Abstract

We determined the association between daily ambulatory activity and markers of inflammation and oxidative stress in patients with peripheral artery disease (PAD) and claudication. Patients with PAD (n = 134) limited by claudication were studied. Patients took 3275 ± 1743 daily strides for 273 ± 112 minutes each day, and their average daily cadence was 11.7 ± 2.7 strides/min. High-sensitivity C-reactive protein was significantly and negatively associated with the total number of daily strides (P < .001), total daily ambulatory time (P < .01), peak activity index (P < .01), daily average cadence (P < .05), and the maximum cadences for 60 minutes (P < .05), 30 minutes (P < .05), 20 minutes (P < .05), and 5 minutes (P < .01). Oxidized low-density lipoprotein and soluble vascular cell adhesion molecule 1 were not significantly associated with any of the ambulatory measures (P > .05). We conclude that higher levels of community-based, daily ambulatory activity are associated with lower levels of inflammation but are not associated with markers of oxidative stress.
© The Author(s) 2013.

Entities:  

Keywords:  C-reactive protein; claudication; oxidized low-density lipoprotein; peripheral artery disease

Mesh：

Substances：

Year:  2013        PMID： 23695338      PMCID： PMC3841224          DOI： 10.1177/0003319713489769

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


  27 in total

1.  Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer.

Authors:  M M McDermott; K Liu; E O'Brien; J M Guralnik; M H Criqui; G J Martin; P Greenland
Journal:  Angiology       Date:  2000-02       Impact factor: 3.619

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

3.  Patterns of ambulatory activity in subjects with and without intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Kristy J Scott; Azhar Afaq; Steve M Blevins
Journal:  J Vasc Surg       Date:  2007-10-24       Impact factor: 4.268

Review 4.  Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation.

Authors:  Carl J Lavie; Timothy S Church; Richard V Milani; Conrad P Earnest
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 May-Jun       Impact factor: 2.081

5.  In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease.

Authors:  E Martínez Aguilar; J De Haro Miralles; A Flórez González; C Varela Casariego; S Bleda Moreno; F Acín García
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-02-10       Impact factor: 7.069

Review 6.  Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies.

Authors:  Eric P Brass; William R Hiatt
Journal:  Vasc Med       Date:  2006-11       Impact factor: 3.239

Review 7.  The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.

Authors:  Iraklis I Pipinos; Andrew R Judge; Joshua T Selsby; Zhen Zhu; Stanley A Swanson; Aikaterini A Nella; Stephen L Dodd
Journal:  Vasc Endovascular Surg       Date:  2007 Dec-2008 Jan       Impact factor: 1.089

Review 8.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

9.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

Authors:  A W Gardner; E T Poehlman
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

Review 10.  The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.

Authors:  Iraklis I Pipinos; Andrew R Judge; Joshua T Selsby; Zhen Zhu; Stanley A Swanson; Aikaterini A Nella; Stephen L Dodd
Journal:  Vasc Endovascular Surg       Date:  2008-04-07       Impact factor: 1.089
View more
  16 in total

1.  Changes in vascular and inflammatory biomarkers after exercise rehabilitation in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery
Journal:  J Vasc Surg       Date:  2019-03-25       Impact factor: 4.268

2.  Sedentary behavior is associated with impaired biomarkers in claudicants.

Authors:  Breno Q Farah; Raphael M Ritti-Dias; Polly S Montgomery; Ana I Casanegra; Federico Silva-Palacios; Andrew W Gardner
Journal:  J Vasc Surg       Date:  2015-10-27       Impact factor: 4.268

3.  Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Omar L Esponda; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  Angiology       Date:  2013-09-03       Impact factor: 3.619

4.  Association between daily walking and antioxidant capacity in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Yan D Zhao; Federico Silva-Palacios; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  J Vasc Surg       Date:  2017-03-01       Impact factor: 4.268

5.  Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.

Authors:  Panagiotis Koutakis; Dimitrios Miserlis; Sara A Myers; Julian Kyung-Soo Kim; Zhen Zhu; Evlampia Papoutsi; Stanley A Swanson; Gleb Haynatzki; Duy M Ha; Lauren A Carpenter; Rodney D McComb; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Histochem Cytochem       Date:  2015-01-09       Impact factor: 2.479

6.  Endothelial Cell Inflammation and Antioxidant Capacity are Associated With Exercise Performance and Microcirculation in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  Angiology       Date:  2015-01-20       Impact factor: 3.619

7.  Association Between Daily Steps at Moderate Cadence and Vascular Outcomes in Patients With Claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen
Journal:  J Cardiopulm Rehabil Prev       Date:  2022-01-01       Impact factor: 2.081

8.  Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  J Vasc Surg       Date:  2014-04-03       Impact factor: 4.268

9.  Synthesis and characterization of a hyaluronic acid-based hydrogel with antioxidative and thermosensitive properties.

Authors:  Meng Chen; Cui Li; Fujiao Nie; Xiaoyan Liu; Iraklis I Pipinos; Xiaowei Li
Journal:  RSC Adv       Date:  2020-09-14       Impact factor: 4.036

10.  Association between meeting daily step count goals with ambulatory function and quality of life in patients with claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen
Journal:  J Vasc Surg       Date:  2020-11-27       Impact factor: 4.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.